XEUM:LSE:LSE-db x-trackers MSCI Europe Mid Cap UCITS DR 1C (GBX)

ETF | Others |

Last Closing

USD 13718

Change

+111.00 (+0.82)%

Market Cap

N/A

Volume

400.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-0.95 (-0.52%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.24 (+1.35%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.11 (+0.80%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+0.33 (+0.29%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.05 (-0.07%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.35 (+1.20%)

USD 259.48B
0QZO:LSE 0QZO

+0.35 (+0.41%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B
0R24:LSE Intel Corp.

-0.06 (-0.30%)

USD 196.14B

ETFs Containing XEUM:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.67% 81% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.67% 80% B- 74% C
Trailing 12 Months  
Capital Gain 3.14% 56% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.14% 50% F 55% F
Trailing 5 Years  
Capital Gain 83.53% 76% C+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.53% 74% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.44% 65% D 68% D+
Dividend Return 10.44% 64% D 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.80% 58% F 75% C
Risk Adjusted Return 88.45% 83% B 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike